Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-038642
Filing Date
2021-10-01
Accepted
2021-10-01 17:00:21
Documents
1
Period of Report
2021-10-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 8913
  Complete submission text file 0000899243-21-038642.txt   11068
Mailing Address 444 MADISON AVENUE 21ST FLOOR NEW YORK NY 10022
Business Address 444 MADISON AVENUE 21ST FLOOR NEW YORK NY 10022 212-705-8800
QVT Financial LP (Reporting) CIK: 0001290162 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-40782 | Film No.: 211299729

Mailing Address 1177 AVENUE OF THE AMERICAS 9TH FLOOR NEW YORK NY 10036
Business Address 1177 AVENUE OF THE AMERICAS 9TH FLOOR NEW YORK NY 10036 212-705-8800
QVT Financial GP LLC (Reporting) CIK: 0001290164 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-40782 | Film No.: 211299728

Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE, 2 CHURCH STREET HAMILTON HM11 D0 HM11 441-295-5950
Roivant Sciences Ltd. (Issuer) CIK: 0001635088 (see all company filings)

EIN.: 981173944 | State of Incorp.: D0 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations